Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: Bo Didley who wrote (1358)	11/3/1999 12:37:00 AM
From: Riverlightning	Respond to of 5582

bo that rule should be they must invest. When they finally are forced to cover it helps drive up the price for you and me.

To: Bo Didley who wrote (1358)	11/3/1999 12:41:00 AM
From: Eric Fader	Read Replies (1) \| Respond to of 5582

Bo - I agree. But we may still have a bit of a dogfight here, since it looked to me like GUMM might have just taken on a few new shorts in the high 18's-19 area. Now THAT would really be stupid... so maybe it's just a little profit-taking by Gunn Allen customers who have doubles from when GNLN was taking in a ton of stock awhile back in the 9's. Wait until this story starts hitting the likes of the Today Show, and we get to see the "guerilla tactics" from Kovel/Fuller. Remember how KIDE shot into the stratosphere as soon as the string of magazine (and IBD) articles hit? IBD should do a story on GUMM too within a couple of weeks, it seems to me, but Zicam will very quickly get massive coverage in the popular press. Then we'll get Leno and Letterman talking about it... This is going to be FUN! -Eric